New FDA-Approved Diabetes App Launched By Roche Holdings

Roche Holding (OTCMKTS:RHHBY), a major pharmaceutical company, is making news for its new diabetes app, which contains a prescription insulin bolus calculator called Bolus Advisor. Mobihealthnews reports that this unique feature gained FDA approval in mid-March for the Android version of the app, and received clearance for the iOS version in early June.
According to the publication:

The app gives people with diabetes a choice of reports to help identify trends and patterns in blood sugar levels and lets them share their data with their caregiver or healthcare team via connected online accounts, email or text message. It receives data from the Accu-Chek Aviva Connect Bluetooth-enabled meter. As of June 27, the app is now available in the United States for both iOS and Android devices.

A Roche spokesperson is quoted, explaining:

The development of the Accu-Chek Connect system underscores Roche Diabetes Care’s commitment to advancing technology that empowers people with diabetes to focus on the daily wins of managing diabetes and living life as normally and actively as possible. Long-term diabetes management success isn’t achieved with one sweeping action, but is realized through a series of small victories that help improve overall patient adherence, clinical outcomes and quality of living.

Click here to read the full article.